Skip to content
Search

Latest Stories

PM visits pharmacy in his Uxbridge constituency

Prime Minister Boris Johnson on Friday visited a local pharmacy in his West London constituency of Uxbridge.

The visit to McParlands Pharmacy was organised by the Association of Independent Multiple Pharmacies (AIMp) to showcase community pharmacy's contribution to the health and wellbeing of the local community.


It's CEO, Leyla Hannbeck, invited the Prime Minister to witness first-hand pharmacy provisions at work within his own constituency.

“It was a real pleasure to meet with Leyla Hannbeck, the CEO of the Association of Independent Multiple Pharmacies, and Corrin McParland and the team at McParlands Pharmacy to learn more about the important work of community pharmacies in helping to keep local people fit and healthy,” PM Johnson said.

“We discussed how the Pharmacy’s involvement in the consultation service has already benefitted a number of my constituents. This has helped relieve pressure on GPs and A&E departments, as well as giving people the treatment they need as quickly and as close to home as possible”.

Hannbeck said by inviting the Prime Minister into a local pharmacy, the AIMp wanted to showcase the work and contribution Community Pharmacy makes to the health and wellbeing of the local community.

“We are delighted we have been able to showcase community pharmacy to the Prime Minister on his visit. I am really grateful to Mr Johnson for accepting my invitation and making time, during his busy schedule to visit the McParland Pharmacy and enable us to talk about community pharmacy provision,” she added.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less